143 related articles for article (PubMed ID: 25099343)
1. Discovery of a novel class of diacylglycerol acyltransferase 2 inhibitors with a 1H-pyrrolo[2,3-b]pyridine core.
Kim MO; Lee S; Choi K; Lee S; Kim H; Kang H; Choi M; Kwon EB; Kang MJ; Kim S; Lee HJ; Lee HS; Kwak YS; Cho S
Biol Pharm Bull; 2014; 37(10):1655-60. PubMed ID: 25099343
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of a selective small molecule inhibitor targeting the diacylglycerol acyltransferase 2 activity.
Kim MO; Lee SU; Lee HJ; Choi K; Kim H; Lee S; Oh SJ; Kim S; Kang JS; Lee HS; Kwak YS; Cho S
Biol Pharm Bull; 2013; 36(7):1167-73. PubMed ID: 23585481
[TBL] [Abstract][Full Text] [Related]
3. The use of stable isotope-labeled glycerol and oleic acid to differentiate the hepatic functions of DGAT1 and -2.
Qi J; Lang W; Geisler JG; Wang P; Petrounia I; Mai S; Smith C; Askari H; Struble GT; Williams R; Bhanot S; Monia BP; Bayoumy S; Grant E; Caldwell GW; Todd MJ; Liang Y; Gaul MD; Demarest KT; Connelly MA
J Lipid Res; 2012 Jun; 53(6):1106-16. PubMed ID: 22493088
[TBL] [Abstract][Full Text] [Related]
4. Diacylglycerol acyltransferase-2 (DGAT2) and monoacylglycerol acyltransferase-2 (MGAT2) interact to promote triacylglycerol synthesis.
Jin Y; McFie PJ; Banman SL; Brandt C; Stone SJ
J Biol Chem; 2014 Oct; 289(41):28237-48. PubMed ID: 25164810
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic Characterization of Long Residence Time Inhibitors of Diacylglycerol Acyltransferase 2 (DGAT2).
Pabst B; Futatsugi K; Li Q; Ahn K
Biochemistry; 2018 Dec; 57(51):6997-7010. PubMed ID: 30422629
[TBL] [Abstract][Full Text] [Related]
6. Diacylglycerol acyltransferase 1/2 inhibition induces dysregulation of fatty acid metabolism and leads to intestinal barrier failure and diarrhea in mice.
Takemoto K; Fukasaka Y; Yoshimoto R; Nambu H; Yukioka H
Physiol Rep; 2020 Aug; 8(15):e14542. PubMed ID: 32786057
[TBL] [Abstract][Full Text] [Related]
7. Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance.
Choi CS; Savage DB; Kulkarni A; Yu XX; Liu ZX; Morino K; Kim S; Distefano A; Samuel VT; Neschen S; Zhang D; Wang A; Zhang XM; Kahn M; Cline GW; Pandey SK; Geisler JG; Bhanot S; Monia BP; Shulman GI
J Biol Chem; 2007 Aug; 282(31):22678-88. PubMed ID: 17526931
[TBL] [Abstract][Full Text] [Related]
8. Roles of Acyl-CoA:Diacylglycerol Acyltransferases 1 and 2 in Triacylglycerol Synthesis and Secretion in Primary Hepatocytes.
Li C; Li L; Lian J; Watts R; Nelson R; Goodwin B; Lehner R
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1080-91. PubMed ID: 25792450
[TBL] [Abstract][Full Text] [Related]
9. Hepatic synthesis of triacylglycerols containing medium-chain fatty acids is dominated by diacylglycerol acyltransferase 1 and efficiently inhibited by etomoxir.
Wunderling K; Leopold C; Jamitzky I; Yaghmour M; Zink F; Kratky D; Thiele C
Mol Metab; 2021 Mar; 45():101150. PubMed ID: 33359403
[TBL] [Abstract][Full Text] [Related]
10. Targeting Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) with small molecule inhibitors for the treatment of metabolic diseases.
Cao J; Zhou Y; Peng H; Huang X; Stahler S; Suri V; Qadri A; Gareski T; Jones J; Hahm S; Perreault M; McKew J; Shi M; Xu X; Tobin JF; Gimeno RE
J Biol Chem; 2011 Dec; 286(48):41838-41851. PubMed ID: 21990351
[TBL] [Abstract][Full Text] [Related]
11. Murine diacylglycerol acyltransferase-2 (DGAT2) can catalyze triacylglycerol synthesis and promote lipid droplet formation independent of its localization to the endoplasmic reticulum.
McFie PJ; Banman SL; Kary S; Stone SJ
J Biol Chem; 2011 Aug; 286(32):28235-46. PubMed ID: 21680734
[TBL] [Abstract][Full Text] [Related]
12. Diacylglycerol acyltransferase-2 and monoacylglycerol acyltransferase-2 are ubiquitinated proteins that are degraded by the 26S proteasome.
Brandt C; McFie PJ; Stone SJ
Biochem J; 2016 Oct; 473(20):3621-3637. PubMed ID: 27531967
[TBL] [Abstract][Full Text] [Related]
13. Diacylglycerol acyltransferase 2 acts upstream of diacylglycerol acyltransferase 1 and utilizes nascent diglycerides and de novo synthesized fatty acids in HepG2 cells.
Wurie HR; Buckett L; Zammit VA
FEBS J; 2012 Sep; 279(17):3033-47. PubMed ID: 22748069
[TBL] [Abstract][Full Text] [Related]
14. Triazolo compounds useful as diacylglycerol acyltransferase1 inhibitor - WO2009126624.
Matsuda D; Tomoda H
Expert Opin Ther Pat; 2010 Aug; 20(8):1097-102. PubMed ID: 20509774
[TBL] [Abstract][Full Text] [Related]
15. DGAT2 Inhibition Alters Aspects of Triglyceride Metabolism in Rodents but Not in Non-human Primates.
McLaren DG; Han S; Murphy BA; Wilsie L; Stout SJ; Zhou H; Roddy TP; Gorski JN; Metzger DE; Shin MK; Reilly DF; Zhou HH; Tadin-Strapps M; Bartz SR; Cumiskey AM; Graham TH; Shen DM; Akinsanya KO; Previs SF; Imbriglio JE; Pinto S
Cell Metab; 2018 Jun; 27(6):1236-1248.e6. PubMed ID: 29706567
[TBL] [Abstract][Full Text] [Related]
16. Discovery and Pharmacology of a Novel Class of Diacylglycerol Acyltransferase 2 Inhibitors.
Imbriglio JE; Shen DM; Liang R; Marby K; You M; Youm HW; Feng Z; London C; Xiong Y; Tata J; Verras A; Garcia-Calvo M; Song X; Addona GH; McLaren DG; He T; Murphy B; Metzger DE; Salituro G; Deckman D; Chen Q; Jin X; Stout SJ; Wang SP; Wilsie L; Palyha O; Han S; Hubbard BK; Previs SF; Pinto S; Taggart A
J Med Chem; 2015 Dec; 58(23):9345-53. PubMed ID: 26561979
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of acyl-CoA:diacylglycerol acyltransferase 2 with antisense oligonucleotide reduces VLDL TG and ApoB secretion in mice.
Liu Y; Millar JS; Cromley DA; Graham M; Crooke R; Billheimer JT; Rader DJ
Biochim Biophys Acta; 2008 Mar; 1781(3):97-104. PubMed ID: 18252207
[TBL] [Abstract][Full Text] [Related]
18. ATF6-DGAT pathway is involved in TLR7-induced innate immune response in Ctenopharyngodon idellus kidney cells.
Wei M; Huang X; Bian C; Sun J; Ji H
Dev Comp Immunol; 2021 Nov; 124():104197. PubMed ID: 34228994
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of [trans-5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl]acetic acid monobenzenesulfonate (JTT-553), a novel acyl CoA:diacylglycerol transferase (DGAT) 1 inhibitor.
Tomimoto D; Okuma C; Ishii Y; Akiyama Y; Ohta T; Kakutani M; Ohkuma Y; Ogawa N
Biol Pharm Bull; 2015; 38(2):263-9. PubMed ID: 25747985
[TBL] [Abstract][Full Text] [Related]
20. Current status of the research and development of diacylglycerol O-acyltransferase 1 (DGAT1) inhibitors.
DeVita RJ; Pinto S
J Med Chem; 2013 Dec; 56(24):9820-5. PubMed ID: 23919406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
